- Gemini Genomics raises $90mm in IPO
- Sequenom buys Gemini Genomics for $224mm in stock
- Merck & Co. acquires Rosetta Inpharmatics
- Vertex acquires Aurora for $570mm
- Rosetta and Gemini Genomics look for disease genes
- CuraGen and Gemini collaborate in pharmacogenomics
- Gemini and Large Scale Biology sign proteomics pact
- Shield and Gemini to co-develop osteoporosis test
- Evotec acquires Oxford Asymmetry
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.